Article

Adult Care for Congenital Heart Disease Patients Should Begin in Adolescence

Doctors should transition their patients from pediatric to adult medical care for congenital heart disease during early adolescence.

Doctors should transition their patients from pediatric to adult medical care for congenital heart disease during early adolescence, experts recommend in a scientific statement published in Circulation: Journal of the American Heart Association.

“It’s not as simple as getting the name of a new doctor and going to see them when a patient turns 18,” said Craig Sable, MD, co-chair of the statement committee and director of echocardiography and cardiology fellowship training at Children’s National Medical Center in Washington, DC. “There are multiple steps associated with the transition process that need to be started at a very young age, so that by the time these children become adults the process is well under way.”

The transition should be a joint effort between the health care provider (usually a pediatric heart specialist), the patient and the patient’s family that starts when patients are between 12 to 14 years old, Sable said.

Critical steps include:

• select an adult care physician to provide and coordinate comprehensive care;

• offer reproductive/genetic and career counseling;

• secure health insurance;

• educate adult care providers in managing congenital heart disease; and

• maintain communication between patients, families, and health care professionals.

Most children born with congenital heart disease today survive into adulthood and live normal lives. In the United States, more than half of those affected are now adults.

However, many patients need specialized and uninterrupted medical treatment. Ideally, the transition process minimizes disruption and stress while maintaining appropriate treatment continuity. But less than one-third of adults with congenital heart disease receive care from qualified, trained specialists, Sable said.

“The vast majority of the patients we see are not necessarily the most severe, so there’s a real concern that some of the patients who really need care are not seeking it,” he said. “The bottom line is to ensure that, as patients grow up, they receive the necessary care.”

Beginning in 2008, Sable and his team researched transition literature to identify the most effective practices that they presented in the paper.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
© 2024 MJH Life Sciences

All rights reserved.